Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL588619 ((8r,9s)-cinchonine, (9s)-cinchonan-9-ol, Cinchonan-9-ol, (9s)-, D-cinchonine, GNF-Pf-3189, NSC-6176, TCMDC-123933) |
---|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Plasmodium falciparum (target type: ORGANISM) [ChEMBL: CHEMBL364] | ||||||||
ChEMBL | Antimicrobial activity against Plasmodium falciparum | F | 4.64 | pIC50 | 23000 | nM | IC50 | Bioorg Med Chem (2010) 18: 2225-2231 [PMID:20185316] |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 assessed as reduction in parasite viability by parasite lactate dehydrogenase assay | F | 6.53 | pIC50 | 292.5 | nM | IC50 | Eur J Med Chem (2015) 100: 10-17 [PMID:26063305] |
ChEMBL | In vitro antimalarial activity against Plasmodium falciparum W2 in human erythrocytes by [3H]hypoxanthine uptake | F | 6.66 | pIC50 | 220 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 1351-1355 [PMID:11992775] |
ChEMBL | Antimalarial activity against chloroquine resistant Plasmodium falciparum Dd2 after 72 hrs by SYBP Green I dye staining | F | 7.09 | pIC50 | 82 | nM | IC50 | Bioorg Med Chem (2012) 20: 3292-3297 [PMID:22512909] |
ChEMBL | Antimalarial activity against chloroquine-resistant Plasmodium falciparum K1 assessed as incorporation of [3H]hypoxanthine after 48 hr microdilution method | F | 7.25 | pIC50 | 56 | nM | IC50 | Med Chem Res (2007) 16: 213-229 |
ChEMBL | In vitro inhibition of parasite development of Plasmodium falciparum W2 in human erythrocytes | F | 7.29 | pIC50 | 51 | nM | IC50 | Bioorg Med Chem Lett (2002) 12: 1351-1355 [PMID:11992775] |
ChEMBL | Antimalarial activity against chloroquine sensitive Plasmodium falciparum HB3 after 72 hrs by SYBP Green I dye staining | F | 7.66 | pIC50 | 22 | nM | IC50 | Bioorg Med Chem (2012) 20: 3292-3297 [PMID:22512909] |
ChEMBL | Antimalarial activity against chloroquine-sensitive Plasmodium falciparum 3D7 assessed as incorporation of [3H]hypoxanthine after 48 hr microdilution method | F | 7.68 | pIC50 | 21 | nM | IC50 | Med Chem Res (2007) 16: 213-229 |
ChEMBL | Antiplasmodial activity against Plasmodium falciparum 3D7 infected in RBCs by firefly luciferase reporter gene assay | F | 8.3 | pIC50 | 5 | nM | IC50 | Antimicrob Agents Chemother (2010) 54: 3597-3604 [PMID:20547797] |
ChEMBL | NOVARTIS: Inhibition of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay | F | 6.96 | pEC50 | 110 | nM | EC50 | Proc Natl Acad Sci U S A (2008) 105: 9059-9064 [PMID:18579783] |
ChEMBL | NOVARTIS: Inhibition of Plasmodium falciparum 3D7 (drug-susceptible) proliferation in erythrocyte-based infection assay | F | 7.02 | pEC50 | 95.3 | nM | EC50 | Proc Natl Acad Sci U S A (2008) 105: 9059-9064 [PMID:18579783] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]